Moderna Advances Hantavirus Vaccine Research, Stock Surges
Moderna is reportedly developing a hantavirus vaccine, a development that has caused the company's stock to jump. This news highlights ongoing efforts to bring hantavirus vaccines and treatments into the pipeline.
Source Diversity
Source Diversity
Moderate (46/100)Sources
Hantavirus Vaccines and Treatments Are in the Pipeline
But it has been hard to attract interest in medical interventions for viruses that have not been considered a top public health priority, scientists say.
By Emily Anthes
Read full article →Vaccine Trade Returns? Moderna Working On Hantavirus Shot Sends Shares Higher
Vaccine Trade Returns? Moderna Working On Hantavirus Shot Sends Shares Higher Moderna is out with timely news that it is working on early-stage research on vaccines targeting hantaviruses. The news comes as a Spanish woman has been hospitalized for a suspected infection, while a hantavirus cluster has ravaged a Dutch-flagged cruise ship, with five confirmed and three suspected cases of hantavirus. Three deaths have been reported so far. Bloomberg reports that Moderna is collabor...
By Tyler Durden
Read full article →
